E-mail Newsletter

  • Enter your e-mail address below to receive the "Patent Docs" e-mail newsletter.

Enter your email address:

Delivered by FeedBurner

Contact the Docs

Docs on Twitter

About the Authors

  • The Authors and Contributors of "Patent Docs" are patent attorneys and agents, many of whom hold doctorates in a diverse array of disciplines.


  • "Patent Docs" does not contain any legal advice whatsoever. This weblog is for informational purposes only, and its publication does not create an attorney-client relationship. In addition, nothing on "Patent Docs" constitutes a solicitation for business. This weblog is intended primarily for other attorneys. Moreover, "Patent Docs" is the personal weblog of the Authors; it is not edited by the Authors' employers or clients and, as such, no part of this weblog may be so attributed. All posts on "Patent Docs" should be double-checked for their accuracy and current applicability.

Become a Fan

« Biotech/Pharma Licensing News | Main | USPTO Implements PPH 2.0 Upgrade »

February 21, 2012


Give me a break! The USA can't even provide the necessary quantities of a 50-year old drug (methotrexate), but now the Obama administration wants to reduce incentives for new drug developments. More b.s. from Obama et al.

Of course, the Administration also said the AIA would produce 200,000 new jobs. I'd like to know what those economists have been smoking.


Obviously not "common sense" when it comes to the Abominable Inane Act.

To Kevin's note, I have seen a phrase that I think sums up the AIA:

Pay more, get less, wait longer.

The comments to this entry are closed.

November 2015

Sun Mon Tue Wed Thu Fri Sat
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30